Glenview Trust co increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 4.6% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 51,836 shares of the healthcare conglomerate's stock after purchasing an additional 2,264 shares during the quarter. Glenview Trust co's holdings in UnitedHealth Group were worth $27,149,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. Ilmarinen Mutual Pension Insurance Co boosted its stake in UnitedHealth Group by 2.0% during the 1st quarter. Ilmarinen Mutual Pension Insurance Co now owns 163,600 shares of the healthcare conglomerate's stock worth $85,686,000 after purchasing an additional 3,200 shares during the last quarter. Advisory Alpha LLC raised its holdings in UnitedHealth Group by 6.9% in the 1st quarter. Advisory Alpha LLC now owns 4,555 shares of the healthcare conglomerate's stock valued at $2,386,000 after acquiring an additional 293 shares during the last quarter. Bayforest Capital Ltd raised its holdings in UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after acquiring an additional 48 shares during the last quarter. Alaethes Wealth LLC raised its holdings in UnitedHealth Group by 2.5% in the 1st quarter. Alaethes Wealth LLC now owns 4,763 shares of the healthcare conglomerate's stock valued at $2,495,000 after acquiring an additional 116 shares during the last quarter. Finally, SCS Capital Management LLC acquired a new stake in UnitedHealth Group in the 1st quarter valued at about $2,414,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.
UnitedHealth Group Stock Up 2.1%
Shares of NYSE UNH traded up $7.11 during midday trading on Thursday, hitting $353.89. 18,916,413 shares of the company's stock were exchanged, compared to its average volume of 19,187,298. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The company has a market cap of $320.51 billion, a PE ratio of 15.33, a P/E/G ratio of 2.27 and a beta of 0.45. The firm's fifty day simple moving average is $291.11 and its 200-day simple moving average is $370.48.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. UnitedHealth Group's revenue was up 12.9% compared to the same quarter last year. During the same period in the previous year, the company posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be given a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.5%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's payout ratio is 38.30%.
Analyst Ratings Changes
A number of equities analysts have recently weighed in on UNH shares. UBS Group reiterated a "buy" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Baird R W cut shares of UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research report on Thursday, July 31st. Truist Financial lifted their price target on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a "buy" rating in a research report on Tuesday. Royal Bank Of Canada decreased their price target on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 30th. Finally, Barclays upped their price target on UnitedHealth Group from $337.00 to $352.00 and gave the stock an "overweight" rating in a research note on Thursday, September 4th. Sixteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $355.77.
View Our Latest Research Report on UNH
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.